About Athyrium Capital Management
Athyrium Capital Management (Athyrium) is a specialized asset management company formed in 2008 by Jeffrey A. Ferrell to focus on investment opportunities in the global healthcare sector. Athyrium invests across healthcare verticals including biopharma, medical devices and products, and healthcare services. The team partners with management teams to implement creative financing solutions to companies' capital needs. In addition, Athyrium manages similar healthcare assets on behalf of other institutional investors.
Athyrium Capital Management Headquarter Location
126 East 56th Street Floor 4
New York, New York, 10022,
Latest Athyrium Capital Management News
Aug 2, 2021
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that it has entered into a note purchase agreement with a fund of Athyrium Capital Management, LP.
Athyrium Capital Management Team
1 Team Member
Athyrium Capital Management has 1 team member, including current Managing Partner, Jeffrey Ferrell.